Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Oncology Institute (TOI) Return on Sales (2021 - 2025)

Oncology Institute's Return on Sales history spans 5 years, with the latest figure at 0.05% for Q4 2025.

  • For Q4 2025, Return on Sales rose 8.0% year-over-year to 0.05%; the TTM value through Dec 2025 reached 0.12%, up 4.0%, while the annual FY2025 figure was 0.12%, 4.0% up from the prior year.
  • Return on Sales reached 0.05% in Q4 2025 per TOI's latest filing, up from 0.12% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 0.35% in Q1 2022 to a low of 0.39% in Q1 2023.
  • Average Return on Sales over 5 years is 0.12%, with a median of 0.15% recorded in 2025.
  • Peak YoY movement for Return on Sales: skyrocketed 37bps in 2022, then tumbled -74bps in 2023.
  • A 5-year view of Return on Sales shows it stood at 0.19% in 2021, then rose by 21bps to 0.15% in 2022, then crashed by -42bps to 0.22% in 2023, then skyrocketed by 40bps to 0.13% in 2024, then skyrocketed by 60bps to 0.05% in 2025.
  • Per Business Quant, the three most recent readings for TOI's Return on Sales are 0.05% (Q4 2025), 0.12% (Q3 2025), and 0.14% (Q2 2025).